New mapping technique may improve heart rhythm procedure
NCT ID NCT03915691
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tests two ways to do a catheter ablation for a type of fast heartbeat called atrial tachycardia that comes from heart scar tissue. One method uses a new mapping system (Ripple Mapping) to guide the ablation, while the other uses the standard approach. The goal is to see which method better prevents the arrhythmia from coming back within a year. About 200 adults who need this procedure are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL TACHYCARDIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Freeman Hospital, The Newcastle Upon Tyne NHS Foundation Trust
Newcastle, NE7 7DN, United Kingdom
-
Imperial College Healthcare NHS Trust
London, W12 0HS, United Kingdom
-
Liverpool Heart & Chest Hospital
London, L14 3PE, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Catheter ablation (Ripple Mapping guided or conventional mapping guided)
What this could lead to
If successful, this could identify a more effective ablation technique to reduce the return of atrial tachycardia after the procedure.
What could go wrong
This is a mid-stage study with no phase designation, and the outcome depends on long-term follow-up. The procedure itself carries standard risks like bleeding or heart damage.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.